Clinical Trial Update: NMDA Antagonists in Bipolar Depression [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating NMDA antagonists for bipolar depression has completed, with results posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder

Snippet

Sponsor: New York State Psychiatric Institute | Conditions: Bipolar Disorder | Phase 4 | Status: COMPLETED | Results posted: 2016-06-01